Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery

المؤلف

Kim, Uoo

المصدر

Case Reports in Anesthesiology

العدد

المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-3، 3ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2020-12-24

دولة النشر

مصر

عدد الصفحات

3

التخصصات الرئيسية

الطب البشري

الملخص EN

Anesthetic management for patients with certain neuromuscular disorders may be challenging due to contraindications to triggering agents secondary to increased susceptibility for malignant hyperthermia (MH).

Inclusion body myositis (IBM) is an inflammatory muscle disease that causes concern for the anesthesiologist due to potential respiratory muscle weakness and hyperkalemia with succinylcholine.

Elevated serum creatinine kinase levels found in IBM also raise the possibility of increased susceptibility to MH.

This case report describes a successful anesthetic course with special considerations in a patient with IBM undergoing general anesthesia for coronary artery bypass grafting (CABG) under cardiopulmonary bypass (CPB) using total intravenous anesthesia (TIVA).

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Kim, Uoo. 2020. Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery. Case Reports in Anesthesiology،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1145955

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Kim, Uoo. Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery. Case Reports in Anesthesiology No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1145955

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Kim, Uoo. Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery. Case Reports in Anesthesiology. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1145955

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1145955